Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Susannah Rose joined the professional staff in the Department of Bioethics at Cleveland Clinic in the fall of 2011. She also holds appointments at the Taussig Cancer Center and the Medicine Institute. She is an Assistant Professor at the Cleveland Clinic Lerner School of Medicine of Case Western Reserve University.
She received her PhD from Harvard University's Health Policy Program in 2010. She also earned an MS in Bioethics from Union College/Albany Medical Center in 2006, and a MS in Social Work from Columbia University in 1998. While at Harvard, she received multiple awards and fellowships: Dr. Rose was a National Institute of Mental Health (NIMH) pre-doctoral research fellow; a Harvard Edmond J. Safra Center for Ethics Graduate Fellow; a Safra post-doctoral lab fellow; and she was also a pre- and post-doctoral fellow at Massachusetts General Hospital, sponsored by the National Cancer Institute (NCI) through the Program in Cancer Research Outcomes Training (PCORT). She also received multiple teaching awards. She has published two books focused on coping with cancer, and she has published and presented in numerous academic venues on topics related to conflicts of interest in medicine, health policy, oncology and bioethics. Before studying at Harvard, Dr. Rose worked as a social work clinician and researcher at Memorial Sloan-Kettering Cancer Center in New York City, specializing in the psychosocial issues surrounding cancer. Her current research focuses upon two primary areas: 1) institutional conflicts of interest, and 2) outcomes in end-of-life care.
She is currently a Cleveland Clinic Clinical Research Scholar (administered through the Clinical & Translational Science Collaborative, CTSC), which supports Dr. Rose’s research in end-of-life care. Dr. Rose also is active in teaching health policy at the medical school, in providing clinical ethics consultation and in mentoring junior researchers.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/23/2015, Dr. Rose has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.